MBRX Moleculin Biotech, Inc.

NASDAQ

$0.60

Moleculin Biotech, Inc. (MBRX) Earnings News

Earnings press releases, previews and reviews for Moleculin Biotech, Inc. (MBRX), newest first.

Friday August 14, 2026 8:30 AM ET

Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial

Friday May 15, 2026 8:30 AM ET

Moleculin Reports First Quarter 2026 Financial Results and Provides Clinical Update on Pivotal MIRACLE Trial